miR-128-2

Jingzhe Jin1, Mingcheng Ren2

  • 1Department of Oncology, Dandong First Hospital, Dandong 118000, Liaoning, China.

PubMed
概括

在肝细胞癌 (HCC) 病例中,血清miR-128-2显著升高. 这种微RNA显示出作为HCC新型诊断标记物的潜力,在区分患者和健康个体方面表现出高准确性.